Sweden's Path to the Frontline - Precision Medicine, Clinical Trials, and Global Leadership

Sweden has all the prerequisites to become a global leader in precision medicine - where advanced diagnostics are used to personalize treatments and create more effective, equitable cancer care. However, fragmented healthcare structures, insufficient digital infrastructure, and outdated regulatory and funding models are hindering progress.

This is not just a medical issue - it's a matter of social sustainability, international competitiveness, and economic efficiency. If Sweden fails to create a coordinated national structure for clinical trials in precision medicine, we risk falling behind in both research and patient benefits - despite our strong foundations.

The seminar focuses on FOCU.SE - a national, platform-based clinical trial in precision medicine - as an engine for how Sweden can unite academia, healthcare, and industry in a joint commitment. Here, some of Sweden's leading stakeholders gather to answer a crucial question: How can we together establish a system that translates research into equitable patient benefits - and where Sweden takes the lead in the global development of precision-based cancer care? The seminar will include audience interaction.

Participants & workshop facilitators: